Validation of the pepsinogen test method for gastric cancer screening using a follow-up study

Gastric Cancer

Volumn 12, Issue 3, 2009, Pages 158-163

  Mizuno, Shigeto ^a   Kobayashi, Masao ^b   Tomita, Shohken ^c   Miki, Ikuya ^a   Masuda, Atsuhiro ^a   Onoyama, Mitsuko ^a   Habu, Yasuki ^d   Inokuchi, Hideto ^e   Watanabe, Yoshiyuki ^f  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^c Kansai Occupational Health Association   (Japan)

^d Saiseikai Noe Hospital   (Japan)

^e HYOGO CANCER CENTER   (Japan)

^f KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Follow up study; Gastric cancer; Pepsinogen; Screening

Indexed keywords

PEPSINOGEN;

ADULT; AGED; ARTICLE; BARIUM MEAL; CANCER SCREENING; CLINICAL ARTICLE; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; JAPAN; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; X RAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PEPSINOGEN A; PREDICTIVE VALUE OF TESTS; REGISTRIES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 73449125856     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-009-0522-y     Document Type: Article

References (30)

1. The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan 2008. Tokyo: Foundation for Promotion of Cancer Research; 2008.
2. A. Oshima N. Hirata T. Ubukata K. Umeda I. Fujimoto 1986 Evaluation of a mass screening program for stomach cancer with a case-control study design Int J Cancer 38 829 833 10.1002/ijc.2910380608 1:STN:280:DyaL2s%2Fot1emug%3D%3D 3793262
3. A. Fukao Y. Tsubono I. Tsuji S. Hisamichi N. Sugahara A. Takano 1995 The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study Int J Cancer 60 45 48 10.1002/ijc.2910600106 1:STN:280:DyaK2M7htlGksw%3D%3D 7814150
4. I.M. Samloff K. Varis T. Ihamaki M. Siurala J.I. Rotter 1982 Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosa histology. A study in relatives of patients with pernicious anemia Gastroenterology 83 204 209 1:CAS:528:DyaL38XkvV2qsbs%3D 7084603
5. K. Miki M. Ichinose A. Shimizu S.C. Huang H. Oka C. Furihata, et al. 1987 Serum pepsinogens as a screening test of extensive chronic gastritis Gastroenterol Jpn 22 133 141 1:STN:280:DyaL2s3ksl2isw%3D%3D 3596151
6. A.M. Nomura G.N. Stemmermann I.M. Samloff 1980 Serum pepsinogen I as a predictor of stomach cancer Ann Intern Med 93 537 540 1:STN:280: DyaL3M%2FmtVKnsw%3D%3D 7436185
7. G.N. Stemmermann I.M. Samloff A.M. Nomura L.K. Heilbrun 1987 Serum pepsinogens I and II and stomach cancer Clin Chim Acta 163 191 198 10.1016/0009-8981(87)90022-2 1:STN:280:DyaL2s7ovVelsQ%3D%3D 3568423 (Pubitemid 17046077)
8. K. Miki M. Ichinose N. Kawamura M. Matsushima H.B. Ahmad M. Kimura, et al. 1989 The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects Jpn J Cancer Res 80 111 114 1:STN:280:DyaL1M3lsVOktQ%3D%3D 2498245
9. K. Miki M. Ichinose K.B. Ishikawa N. Yahagi M. Matsushima N. Kakei, et al. 1993 Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer Jpn J Cancer Res 84 1086 1090 1:STN:280:DyaK2c%2Fkt1Cguw%3D%3D 8226283
10. C. Hamashima D. Shibuya H. Yamazaki K. Inoue A. Fukao H. Saito, et al. 2008 The Japanese guidelines for gastric cancer screening Jpn J Clin Oncol 38 259 267 10.1093/jjco/hyn017 18344316 (Pubitemid 351583989)
11. A. Miles J. Cockburn R.A. Smith J. Wardle 2004 A perspective from countries using organized screening programs Cancer 101 1201 1213 10.1002/cncr.20505 15316915
12. Statistics and Information Department, Ministry of Health, Labour, and Welfare. National reports on cancer screening programs 2004. Tokyo: Health and Welfare Statistics Association; 2006.
13. R. Murakami H. Tsukuma T. Ubukata K. Nakanishi I. Fujimoto T. Kawashima, et al. 1990 Estimation of validity of mass screening program for gastric cancer in Osaka, Japan Cancer 65 1255 1260 10.1002/1097-0142(19900301)65:5<1255:: AID-CNCR2820650536>3.0.CO;2-P 1:STN:280:DyaK3c7ltVSntw%3D%3D 2302674
14. N. Sugawara Y. Hirasawa T. Morimoto S. Sibuki T. Kogane H. Sato, et al. 1992 An investigative report about health state of old age groups at first screening for gastric mass survey (in Japanese) J Gastroenterol Mass Surv 95 184 186
15. A. Fukao S. Hisamichi A. Takano N. Sugawara 1992 Accuracies of mass screening for gastric cancer-test sensitivity and program sensitivity (in Japanese) J Gastroenterol Mass Surv 97 59 63
16. T. Ishida T. Suematsu K. Obayashi Y. Takada S. Kimura C. Suematsu 1994 Measurement of accuracy of stomach mass screening by population-based cancer registration (in Japanese) J Gastroenterol Mass Surv 32 9 16
17. M. Hattori M. Fujita O. Hosokawa S. Yamazaki 1998 A clinicopathological evaluation of false negative cases in gastric cancer mass survey (in Japanese) J Gastroenterol Mass Surv 36 468 475
18. S. Abe D. Shibuya T. Noguchi T. Shimada 2000 An estimate of the false-negative rate of mass-screening for gastric carcinoma (in Japanese) J Gastroenterol Mass Surv 38 475 482
19. P. Sipponen M. Kekki J. Haapakoski T. Ihamaki M. Siurala 1985 Gastric cancer risk in chronic gastritis: statistical calculations of cross-sectional data Int J Cancer 35 173 177 10.1002/ijc.2910350206 1:STN:280: DyaL2M7ivFKgtw%3D%3D 3871738 (Pubitemid 16179958)
20. P. Correa 1992 Human gastric carcinogenesis: a multi-step and multi-factorial process, First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 52 6735 6740 1:CAS:528: DyaK3sXjs1Orsw%3D%3D 1458460
21. M. Tatsuta H. Iishi A. Nakaizumi S. Okuda H. Taniguchi T. Hiyama, et al. 1993 Fundal atrophic gastritis as a risk factor for gastric cancer Int J Cancer 53 70 74 10.1002/ijc.2910530114 1:STN:280:DyaK3s%2FptlygsQ%3D%3D 8416206 (Pubitemid 23018425)
22. K. Kimura 1972 Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach Gastroenterology 63 584 592 1:STN:280:DyaE3s%2Fhs1Gltw%3D%3D 5077145
23. I.M. Samloff 1971 Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence Gastroenterology 61 185 188 1:STN:280:DyaE3M3msVarsw%3D%3D 4935210
24. I.M. Samloff W.M. Liebman 1973 Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence Gastroenterology 65 36 42 1:CAS:528:DyaE3sXltVentrg%3D 4124404
25. Y. Hattori H. Tashiro T. Kawamoto Y. Kodama 1995 Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens Jpn J Cancer Res 86 1210 1215 1:CAS:528:DyaK28XnsFOmtA%3D%3D 8636012
26. A. Kodoi M. Yoshihara K. Sumii K. Haruma G. Kajiyama 1995 Serum pepsinogen in screening for gastric cancer J Gastroenterol 30 452 460 10.1007/BF02347560 1:CAS:528:DyaK2MXnsVWrtLg%3D 7550854
27. M. Yoshihara K. Sumii K. Haruma K. Kiyohira N. Hattori S. Tanaka, et al. 1997 The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography Hiroshima J Med Sci 46 81 86 1:STN:280:DyaK2sznslWrtQ%3D%3D 9232936
28. F. Kitahara K. Kobayashi T. Sato Y. Kojima T. Araki M.A. Fujino 1999 Accuracy of screening for gastric cancer using serum pepsinogen concentrations Gut 44 693 697 1:STN:280:DyaK1M3itFKrug%3D%3D 10205207
29. K. Miki M. Morita M. Sasajima R. Hoshina E. Kanda Y. Urita 2003 Usefulness of gastric cancer screening using the serum pepsinogen test method Am J Gastroenterol 98 735 739 10.1111/j.1572-0241.2003.07410.x 12738449 (Pubitemid 36576295)
30. H. Ohata M. Oka K. Yanaoka Y. Shimizu C. Mukoubayashi K. Mugitani, et al. 2005 Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography Cancer Sci 96 713 720 10.1111/j.1349-7006.2005.00098.x 1:CAS:528:DC%2BD2MXht1WqtLrF 16232204 (Pubitemid 41723549)